News Daily News New-Onset A-fib Tied to Particularly Poor Outcomes After TAVR Todd Neale October 18, 2019
News Daily News Drug Abuse in Infective Endocarditis Patients Spikes Amid US Opioid Epidemic Caitlin E. Cox October 02, 2019
News Conference News TCT 2019 TCT 2019: Pharmacotherapy in PCI, Head-to-Head Valves, YouTube Rappers, and More Shelley Wood September 19, 2019
News Conference News ESC 2019 Reduced-Dose Rivaroxaban May Be an Option After LAA Occlusion, ADRIFT Hints Todd Neale September 11, 2019
News Conference News ESC 2019 LAA Occluders, NOACs Provide Similar Outcomes in High-risk A-fib Patients: PRAGUE-17 Todd Neale September 10, 2019
News Conference News ESC 2019 ESC 2019: Antiplatelets in Diabetes, CAD and A-fib, an ARNI in HFpEF, Staged Complete PCI, and More Shelley Wood August 22, 2019
News Daily News Antiplatelets Protective Post-TAVR in A-fib Patients: PARTNER II Data Caitlin E. Cox August 21, 2019
News Daily News RAS Inhibition After TAVR Gains More Support, but RCT Still Needed Todd Neale July 29, 2019
News Industry News Correvio Resubmits Brinavess (Vernakalant) New Drug Application to U.S. FDA for the Treatment of Patients with Recent Onset Atrial Fibrillation June 24, 2019
News Conference News TVT 2019 PCI During or After TAVR No Riskier Than PCI Before Valve Replacement Michael O'Riordan June 13, 2019
News Industry News GORE® CARDIOFORM ASD Occluder Receives FDA Approval for the Treatment of Atrial Septal Defects June 04, 2019
News Conference News SCAI 2019 Cancer and CV Disease Care: What’s Known? What Lies Ahead for Cardio-Oncology? Yael L. Maxwell May 30, 2019
News Conference News EuroPCR 2019 Off to EuroPCR 2019? Expect Mitral and Tricuspid Updates, Thin-Strut Stent Surprises, and ‘Strong’ Statements Shelley Wood May 16, 2019
News Industry News Cordis Continues to Expand Interventional Cardiology Portfolio with Radial Offering May 14, 2019